Factor analysis on serum biomarkers in patients with stage Ⅰ silicosis
ZOU-Ji-min-YUAN-Bao-jun-WANG-Dong-mei-LI-Chao-GAO-Li-chang-TONG-Yan-yan-CUI-Jing-jing.
China Occupational Medicine
; (6): 687-691, 2022.
Artículo en Zh | WPRIM | ID: wpr-976102
Documentos relacionados
[Expression of <i>LIAS</i> and <i>NRF2</i> in PBMCs from patients with silicosis and their correlation with silicosis].
Exploratory study on noninvasive biomarker of silicosis in exhaled breath by solid-phase microextraction-gas chromatography-mass spectrometry analysis.
[Analysis of the pulmonary function characteristics and associated factors in silicosis patients with progressive massive fibrosis].
Plasma Cytokine Profiling Reveals Differences between Silicotic Patients with Simple Silicosis and Those with Progressive Massive Fibrosis Caused by Engineered Stone.
Combined application of multiple biomarkers for early auxiliary diagnosis of silicosis.
Identification of key pathways and genes in the progression of silicosis based on WGCNA.
Bioinformatics analysis reveals lipid metabolism may play an important role in the SiO<sub>2</sub>-stimulated rat model.
[The study of the impact by atractylenolide-1 on inflammatory cytokine, autophagy and apoptosis in alveolar macrophages of silicosis patients].
[Differential expression of PRDX4 in alveolar macrophages of patients with silicosis].
[Research progress of macrophage polarization in silicosis fibrosis].